Champions Oncology
CSBR
45 hedge funds and large institutions have $81.3M invested in Champions Oncology in 2021 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 19 increasing their positions, 15 reducing their positions, and 3 closing their positions.
27% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 15
6% more capital invested
Capital invested by funds: $76.9M → $81.3M (+$4.45M)
0.44% more ownership
Funds ownership: 53.34% → 53.78% (+0.44%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4% less funds holding
Funds holding: 47 → 45 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MAG
Millrace Asset Group
Berwyn,
Pennsylvania
|
+$902K |
| 2 |
RC
Roubaix Capital
Denver,
Colorado
|
+$845K |
| 3 |
Wells Fargo
San Francisco,
California
|
+$504K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$376K |
| 5 |
Renaissance Technologies
New York
|
+$77.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EI
EAM Investors
Solana Beach,
California
|
-$1.08M |
| 2 |
ZCM
Zebra Capital Management
Stamford,
Connecticut
|
-$346K |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$253K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$213K |
| 5 |
ISL
Ingalls & Snyder LLC
New York
|
-$69.6K |
CSBR Hedge Fund Activity: Q1 2021 in Review
45 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Champions Oncology (CSBR) for Q1 2021, worth a combined $81.3M — up 5.8% from $76.9M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of CSBR and 1 opened new positions — a net loss of 2 holders — while 15 trimmed existing stakes and 19 added.
The largest buyer was Millrace Asset Group, adding an estimated $902K. The largest seller was EAM Investors, exiting entirely with an estimated $1.08M sold.
- 45 institutional investors held Champions Oncology (CSBR) as of Q1 2021, down from 47 in Q4 2020.
- Funds reported $81.3M of Champions Oncology stock for Q1 2021, up 5.8% quarter-over-quarter.
- 1 fund opened new Champions Oncology positions in Q1 2021 and 3 closed out, a net change of -2 holders.
- The largest Champions Oncology buyer in Q1 2021 was Millrace Asset Group, an estimated $902K added.
- The largest Champions Oncology seller in Q1 2021 was EAM Investors, an estimated $1.08M sold.
Based on aggregated 13F filings for Q1 2021.